Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126027021 | 12602702 | 1 | I | 201511 | 20151207 | 20160728 | 20160728 | EXP | US-GLAXOSMITHKLINE-US2015JPN182120 | GLAXOSMITHKLINE | 78.00 | YR | F | Y | 0.00000 | 20160728 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126027021 | 12602702 | 1 | SS | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | Unknown | U | 0 | 4 | MG | SOLUTION FOR INJECTION | |||||||
| 126027021 | 12602702 | 2 | SS | BACLOFEN EMULSION FOR INJECTION/INFUSION | BACLOFEN | 1 | Intrathecal | 0 | 1340.3 | UG | EMULSION FOR INJECTION/INFUSION | QD | |||||||
| 126027021 | 12602702 | 3 | SS | BACLOFEN EMULSION FOR INJECTION/INFUSION | BACLOFEN | 1 | Intrathecal | 0 | 1205 | UG | EMULSION FOR INJECTION/INFUSION | QD | |||||||
| 126027021 | 12602702 | 4 | SS | SLOW K | POTASSIUM CHLORIDE | 1 | Unknown | U | 0 | PROLONGED-RELEASE TABLET | |||||||||
| 126027021 | 12602702 | 5 | SS | HEPARIN SODIUM. | HEPARIN SODIUM | 1 | Unknown | U | 0 | 5000 | DF | ||||||||
| 126027021 | 12602702 | 6 | PS | MAALOX ANTACID | ALUMINUM HYDROXIDEDIMETHICONEMAGNESIUM HYDROXIDE | 1 | Unknown | U | 999999 | ||||||||||
| 126027021 | 12602702 | 7 | SS | CLONIDINE. | CLONIDINE | 1 | Intrathecal | 0 | 150.78 | UG | QD | ||||||||
| 126027021 | 12602702 | 8 | SS | CLONIDINE. | CLONIDINE | 1 | Intrathecal | 0 | 135.66 | UG | QD | ||||||||
| 126027021 | 12602702 | 9 | SS | TYLENOL | ACETAMINOPHEN | 1 | Unknown | U | 0 | ||||||||||
| 126027021 | 12602702 | 10 | SS | ROCEPHIN | CEFTRIAXONE SODIUM | 1 | Unknown | U | 0 | 1 | G | ||||||||
| 126027021 | 12602702 | 11 | SS | COLACE | DOCUSATE SODIUM | 1 | Unknown | U | 0 | 100 | MG | ||||||||
| 126027021 | 12602702 | 12 | SS | APRESOLINE HYDROCHLORIDE | HYDRALAZINE HYDROCHLORIDE | 1 | Unknown | U | 0 | 10 | MG | EMULSION FOR INJECTION/INFUSION | |||||||
| 126027021 | 12602702 | 13 | SS | PROTONIX | PANTOPRAZOLE SODIUM | 1 | Unknown | U | 0 | 40 | MG | ||||||||
| 126027021 | 12602702 | 14 | SS | GLYCOLAX | POLYETHYLENE GLYCOL 3350 | 1 | Unknown | U | 0 | 17 | G | ||||||||
| 126027021 | 12602702 | 15 | SS | KAY CIEL | POTASSIUM CHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 126027021 | 12602702 | 16 | SS | COMPAZINE | PROCHLORPERAZINE MALEATE | 1 | Unknown | U | 0 | 25 | MG | ||||||||
| 126027021 | 12602702 | 17 | SS | PHENERGAN | PROMETHAZINE HYDROCHLORIDE | 1 | Unknown | U | 0 | EMULSION FOR INJECTION/INFUSION | |||||||||
| 126027021 | 12602702 | 18 | SS | ABTEI MEERSALZ NASENSPRAY NASAL SPRAY | SODIUM CHLORIDE | 1 | Unknown | U | 0 | NASAL SPRAY | |||||||||
| 126027021 | 12602702 | 19 | SS | MAGNESIUM SULFATE. | MAGNESIUM SULFATE | 1 | Unknown | U | 0 | 4 | G | ||||||||
| 126027021 | 12602702 | 20 | SS | REGLAN | METOCLOPRAMIDE HYDROCHLORIDE | 1 | Unknown | U | 0 | 10 | MG | EMULSION FOR INJECTION/INFUSION | |||||||
| 126027021 | 12602702 | 21 | SS | ALOE VESTA OINTMENT (MICONAZOLE NITRATE) | MICONAZOLE NITRATE | 1 | Unknown | U | 0 | OINTMENT |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126027021 | 12602702 | 2 | Muscle spasticity |
| 126027021 | 12602702 | 4 | Product used for unknown indication |
| 126027021 | 12602702 | 5 | Product used for unknown indication |
| 126027021 | 12602702 | 6 | Product used for unknown indication |
| 126027021 | 12602702 | 7 | Muscle spasticity |
| 126027021 | 12602702 | 9 | Product used for unknown indication |
| 126027021 | 12602702 | 10 | Product used for unknown indication |
| 126027021 | 12602702 | 12 | Product used for unknown indication |
| 126027021 | 12602702 | 13 | Product used for unknown indication |
| 126027021 | 12602702 | 14 | Product used for unknown indication |
| 126027021 | 12602702 | 15 | Product used for unknown indication |
| 126027021 | 12602702 | 16 | Product used for unknown indication |
| 126027021 | 12602702 | 17 | Product used for unknown indication |
| 126027021 | 12602702 | 18 | Product used for unknown indication |
| 126027021 | 12602702 | 19 | Product used for unknown indication |
| 126027021 | 12602702 | 20 | Product used for unknown indication |
| 126027021 | 12602702 | 21 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126027021 | 12602702 | OT |
| 126027021 | 12602702 | LT |
| 126027021 | 12602702 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126027021 | 12602702 | Acute respiratory failure | |
| 126027021 | 12602702 | Atelectasis | |
| 126027021 | 12602702 | Confusional state | |
| 126027021 | 12602702 | Device malfunction | |
| 126027021 | 12602702 | Diverticulum | |
| 126027021 | 12602702 | Encephalopathy | |
| 126027021 | 12602702 | Hypokalaemia | |
| 126027021 | 12602702 | Hypoxia | |
| 126027021 | 12602702 | Iatrogenic injury | |
| 126027021 | 12602702 | Incorrect dose administered by device | |
| 126027021 | 12602702 | Malaise | |
| 126027021 | 12602702 | Mental status changes | |
| 126027021 | 12602702 | Multiple sclerosis | |
| 126027021 | 12602702 | Seizure | |
| 126027021 | 12602702 | Sepsis | |
| 126027021 | 12602702 | Septic shock | |
| 126027021 | 12602702 | Sleep apnoea syndrome | |
| 126027021 | 12602702 | Unresponsive to stimuli | |
| 126027021 | 12602702 | Urinary tract infection | |
| 126027021 | 12602702 | Vitamin B12 deficiency |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |